Viral oncogenesis and tumor virotherapy

( views:134, downloads:0 )
Author:
WU Ke-fu(Chinese Academy of Medical Science, Peking Union Medical College, Institute of Hematology and Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Tianjin 300020,China)
MA Xiao-tong(Chinese Academy of Medical Science, Peking Union Medical College, Institute of Hematology and Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Tianjin 300020,China)
ZHENG Guo-guang(Chinese Academy of Medical Science, Peking Union Medical College, Institute of Hematology and Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Tianjin 300020,China)
SONG Yu-hua(Chinese Academy of Medical Science, Peking Union Medical College, Institute of Hematology and Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Tianjin 300020,China)
Journal Title:
Journal of Leukemia & Lymphoma
Issue:
Volume 21, Issue 06, 2012
DOI:
10.3760/cma.j.issn.1009-9921.2012.06.001
Key Word:
Oncogenic virus;Viral oncogenesis;Oncolytic virus;Oncolytic virotherapy

Abstract: After near a century of research,the diverse and complicated relationship between viruses and tumors has been elucidated gradually.Last century it was demonstrated that some retroviruses and some herpes viruses could induce lymphoma and leukemia in some animals.However,it is more complicated in human.During the last two decades it has been confirmed that several types of hepatitis viruses could cause hepatocellular carcinoma and the relationship between human papillomaviruses and cervix carcinoma has been established.These viral vaccines became useful tools to prevent prevalence of these carcinomas.Because of the successful inoculation of live attenuated viral vaccines all around the world in recent 15 years,oncolytic virotherapy is revived,and provides a novel strategy for treatment of refractory tumors.

  • [1]Holmes EC.What does virus evolution tell us about virus origins.J Virol.2011,85:5247-5251.
  • [2]吴克复,马小彤,郑国光,等.造血系统的人类疱疹病毒潜伏感染.中国实验血液学杂志,2008,16:1251-1256.
  • [3]吴克复,马小彤,郑国光,等.人类疱疹病毒与肿瘤.白血病·淋巴瘤,2011,20:584-586.
  • [4]吴克复.免疫的细胞社会生态学原理.北京:科学出版社(出版中),2012.
  • [5]Maeda N,Fan H,Yoshikai Y.Oncogenesis by retroviruses:old and new paradigms.Rev Med Virol.2008,18:387-405.
  • [6]Neuveut C,Wei Y,Buendia MA.Mechanisms of HBV-related hepatocarcinogenesis.J Hepatol.2010,52:594-604.
  • [7]Tay SK.Cervical cancer in the human papillomavirus vaccination era.Curr Opin Obstet Gynecol,2012,24:3-7.
  • [8]da Silva SR,de Oliveira DE.HIV,EBV and KSHV:viral cooperation in the pathogenesis of human malignancies.Cancer Lett,2011,305:175-185.
  • [9]Szostek S,Zawilinska B,Kopec J.et al.Herpesviruses as possible cofactors in HPV-16-related oncogenesis.Acta Biochim Pol,2009,56:337-342.
  • [10]White MK,KhaliliK.Expression of JC virus regulatory proteins in human cancer:potential mechanisms for tumouigenesis.Eur J Cancer,2005,41:2537-2548.
  • [11]Schanab O,Humer J,Gleiss A,et al.Expression of human endogenous retrovirus K is stimulmed by ultraviolet radiation in melanoma.Pigment Cell Melanoma Res,2011,24:656-665.
  • [12]Horie M,Tomonga K.Non-retroviral fossls in vertebrate genomes.Viruses,2011,3:1836-1848.
  • [13]吴克复,郑国光,马小彤,等.白血病的复发机制:老问题,新视角.中国实验血液学杂志,2011,19:557-560.
  • [14]Thirukkumaran CM,Morris DG.Oncolytic viroherapy for multiple myeloma:past,present,and future.Bone Marr Res,2011:632948.
  • [15]Lettieri CK,Hingorani P,Kolb EA.Progress of oncolytic viruses in sarcomas.Expert Rev Anticancer Ther,2012,12:229-242.
  • [16]Galanis E.Therapeutic potential of oncolytic measles virus:promises and challenges.Clin Pharm Ther,2010,88:620-25.
  • [17]Donnelly OG,Errington-Mais F,Steele L,et al.Measles virus causes immunogenic cell death in human melanoma.Gene Ther,2011,[Epub ahead of print].
  • [18]Karapanagiotou EM,Roulstone V,Twigger K,et al.Phase Ⅰ/Ⅱ trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies.Clin Cancer Res,2012,18:2080-2089.
  • [19]John LB,Howland LJ,Flynn JK,et al.Oncolytic virus and anti-4-1BB combination therapy elicits strong anti-tumor immunity against established cancer.Cancer Res,2012,72:1651-1660.
  • [20]Guse K,Cerullo V,Hemminki A.Oncolytic vaccinia virus for the treatment of cancer.Expert Opin Biol Ther,2011,11:595-608.
  • [21]Goetz C,Gromeier M.Preparing an oncolytic poliovins recombinant for clinical application against glioblastoma multiforme.Cytokine Growth Factor Rev,2010,21:197-203.
  • [22]Lech PJ,Russell SJ.Use of attenuated parsmmyxoviruses for cancer therapy.Expert Rev Vaccines,2010,9:1275-1302.
  • [23]Bais S,Bartee E,Rahmsn MM,et al.Oncolytic virotherapy for hematological malignancies.Adv Virol,2012:186512.
  • [24]Bridle BW,Hanson S,Lichty BD.Combining oncolytic virotherapy and tumour vaecination.Cytokine Growth Factor Rev,2010,21:143-148.
  • [25]Rahman MM,Madlambayan GJ,Cogle CR,et al.Oncolytic viral purging of leukemic hermatopoietic,stem and progenitor cells with Myxoma virus.Cytokine Growth Factor Rev,2010,21:169-175.
  • [26]Madlambayan GJ,Bartee E,Kim M,et al.Acute myeloid leukemia tsrgeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro.Leuk Res,2012,36:619-624.
  • [27]Wodarz D.Use of oncolytic vinuses for the eradication of drug-resistant cancer cells.J R Soc Interface,2009,6:179-186.
  • [28]Tumilasci VF,Olière S,Nguyen TL,et al.Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced onco1ysis.J Virol,2008,82:8487-8499.
  • [29]吴克复,郑国光,马小彤,等.播散肿瘤治疗策略的共进化分析.中国实验血液学杂志,2012,20:523-526.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn